We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NYSE:HSP | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 89.95 | 0.00 | 00:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-31946
HOSPIRA, INC.
(Exact name of registrant as specified in its charter)
235 East 42nd Street
New York, New York 10017
(212) 733-2323
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
6.05% Notes due 2017 (the 2017 Notes)
5.20% Notes due 2020 (the 2020 Notes)
5.80% Notes due 2023 (the 2023 Notes)
5.60% Notes due 2040 (the 2040 Notes)
Unissued securities registered under the Automatic Shelf Registration Statement on Form S-3 (File No. 333-190256)
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or
suspend the duty to file reports:
Rule 12g-4(a)(1) | ¨ | |
Rule 12g-4(a)(2) | ¨ | |
Rule 12h-3(b)(1)(i) | x | |
Rule 12h-3(b)(1)(ii) | ¨ | |
Rule 15d-6 | ¨ |
Approximate number of holders of record as of the certification or notice date:
2017 Notes: 36
2020 Notes: 24
2023 Notes: 25
2040 Notes: 19
Pursuant to the requirements of the Securities Exchange Act of 1934, Hospira, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: October 6, 2015
By: | /s/ Margaret M. Madden | |
Name: Margaret M. Madden | ||
Title: Director and Authorized Signatory |
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
1 Year Hospira Chart |
1 Month Hospira Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions